 Failure vasoldilator infusion pulmonary diffusing capacity systemic sclerosis PURPOSE Patients systemic sclerosis SSc normal increase diffusing capacity carbon monoxide DLCO supine position potent prostacyclin derivative vasodilator iloprost defect PATIENTS METHODS Fourteen patients SSc randomized double-blind placebo-controlled study iloprost Patients days iloprost placebo infusion upright supine pulmonary function studies RESULTS results baseline pulmonary function studies DLCO iloprost Furthermore iloprost abnormal postural DLCO response CONCLUSION results pulmonary vascular defects group patients consequence reversible pulmonary vasospasm